Michael Anthony Cawthorne
Corporate Officer/Principal bei University of Buckingham
Profil
Michael Anthony Cawthorne is currently the Director-Metabolic Research at the University of Buckingham.
Previously, he worked as a Non-Executive Director at Bridge Bioresearch Plc, a Group Director at SmithKline Beecham Ltd., and as the Founding Secretary at the International Association for the Study of Obesity.
Aktive Positionen von Michael Anthony Cawthorne
| Unternehmen | Position | Beginn |
|---|---|---|
| University of Buckingham | Corporate Officer/Principal | 15.06.2011 |
Ehemalige bekannte Positionen von Michael Anthony Cawthorne
| Unternehmen | Position | Ende |
|---|---|---|
SmithKline Beecham Ltd.
 SmithKline Beecham Ltd. Pharmaceuticals: MajorHealth Technology Smithkline Beecham Ltd. manufacture of basic pharmaceutical products. It also provides mineral water, bottled water, and soft drinks. The company was founded on January 24, 1989 and is headquartered in Brentford, the United Kingdom. | Corporate Officer/Principal | - |
| International Association for the Study of Obesity | Unternehmenssekretär | - |
Bridge Bioresearch Plc
 Bridge Bioresearch Plc Medical/Nursing ServicesHealth Services Bridge Bioresearch Plc develops drug for obesity and metabolic disorders. It is a drug development company focusing on general phase 2a clinical trials as well as acquisition of novel drugs for treatment of widespread metabolic disorders, within the field of life style induced diseases such as Obesity, Type 2 Diabetes and Hypertension. The company is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Bridge Bioresearch Plc
Bridge Bioresearch Plc Medical/Nursing ServicesHealth Services Bridge Bioresearch Plc develops drug for obesity and metabolic disorders. It is a drug development company focusing on general phase 2a clinical trials as well as acquisition of novel drugs for treatment of widespread metabolic disorders, within the field of life style induced diseases such as Obesity, Type 2 Diabetes and Hypertension. The company is headquartered in London, the United Kingdom. | Health Services |
SmithKline Beecham Ltd.
SmithKline Beecham Ltd. Pharmaceuticals: MajorHealth Technology Smithkline Beecham Ltd. manufacture of basic pharmaceutical products. It also provides mineral water, bottled water, and soft drinks. The company was founded on January 24, 1989 and is headquartered in Brentford, the United Kingdom. | Health Technology |
| International Association for the Study of Obesity |
